We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+2.14%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$36.9B
AUM Growth
-$216M
(-0.58%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
8.45%
Holding
2,522
New
303
Increased
944
Reduced
1,005
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$240M |
| 3 |
Chevron
CVX
|
+$231M |
| 4 |
Amazon
AMZN
|
+$183M |
| 5 |
Citigroup
C
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$277M |
| 2 |
Lowe's Companies
LOW
|
+$253M |
| 3 |
Home Depot
HD
|
+$246M |
| 4 |
Danaher
DHR
|
+$174M |
| 5 |
Cisco
CSCO
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.03% |
| 2 | Technology | 15.23% |
| 3 | Healthcare | 11.73% |
| 4 | Industrials | 11.36% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFT
2151
DELISTED
Weatherford International plc
WFT
| $200K | ﹤0.01% |
+87,124
| New | +$278K |
|
2152
Aurinia Pharmaceuticals
AUPH
$1.97B
| $197K | ﹤0.01% |
37,900
-10,500
| -22% | -$56.2K |
|
2153
Perdoceo Education
PRDO
$1.9B
| $197K | ﹤0.01% |
+14,973
| New | +$192K |
|
2154
Voyager Therapeutics
VYGR
$187M
| $197K | ﹤0.01% |
+10,500
| New | +$227K |
|
|
WPX
2155
DELISTED
WPX Energy, Inc.
WPX
| $197K | ﹤0.01% |
+13,300
| New | +$192K |
|
|
ANW
2156
DELISTED
Aegean Marine Petroleum Network
ANW
| $197K | ﹤0.01% |
87,700
-39,000
| -31% | -$142K |
|
2157
VICI Properties
VICI
$29.4B
| $196K | ﹤0.01% |
+10,700
| New | +$209K |
|
|
ASRT
2158
DELISTED
Assertio
ASRT
| $195K | ﹤0.01% |
492
-2,185
| -82% | -$957K |
|
2159
Americold
COLD
$4.09B
| $191K | ﹤0.01% |
+10,000
| New | +$181K |
|
|
UBNK
2160
DELISTED
United Financial Bancorp, Inc.
UBNK
| $188K | ﹤0.01% |
+11,590
| New | +$192K |
|
2161
Lifecore Biomedical
LFCR
$162M
| $187K | ﹤0.01% |
14,358
-1,800
| -11% | -$23.7K |
|
|
TRIB
2162
Trinity Biotech
TRIB
$5.7M
| $184K | ﹤0.01% |
238
-38
| -14% | -$31.1K |
|
|
PCMI
2163
DELISTED
PCM, Inc
PCMI
| $183K | ﹤0.01% |
22,000
-6,500
| -23% | -$56.2K |
|
2164
Pearson
PSO
$9.78B
| $177K | ﹤0.01% |
+16,800
| New | +$167K |
|
|
PGRE
2165
DELISTED
Paramount Group
PGRE
| $174K | ﹤0.01% |
12,200
-37,876
| -76% | -$552K |
|
|
CLCT
2166
DELISTED
Collectors Universe
CLCT
| $173K | ﹤0.01% |
11,000
-2,600
| -19% | -$54.6K |
|
2167
Lineage Cell Therapeutics
LCTX
$257M
| $167K | ﹤0.01% |
71,155
-31,776
| -31% | -$74.5K |
|
|
UMH
2168
UMH Properties
UMH
$1.32B
| $167K | ﹤0.01% |
12,446
-9,100
| -42% | -$118K |
|
|
BAS
2169
DELISTED
Basis Energy Services, Inc.
BAS
| $166K | ﹤0.01% |
+11,500
| New | +$223K |
|
|
SMRT
2170
DELISTED
Stein Mart Inc
SMRT
| $165K | ﹤0.01% |
108,342
+30,800
| +40% | +$28.8K |
|
|
ACH
2171
DELISTED
Alum Corp of China Ltd
ACH
| $164K | ﹤0.01% |
11,800
+100
| +0.9% | +$1.6K |
|
2172
Marchex
MCHX
$79.7M
| $163K | ﹤0.01% |
59,600
-200
| -0.3% | -$646 |
|
2173
Verastem
VSTM
$532M
| $163K | ﹤0.01% |
4,567
-1,716
| -27% | -$66.5K |
|
|
CPRX
2174
DELISTED
Catalyst Pharmaceutical
CPRX
| $158K | ﹤0.01% |
66,300
-11,792
| -15% | -$39.2K |
|
|
MOBL
2175
DELISTED
MobileIron, Inc.
MOBL
| $158K | ﹤0.01% |
31,900
+3,900
| +14% | +$17.7K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Two Sigma Advisers held 2,522 positions worth $36.9B, down 0.58% from $37.1B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Two Sigma Advisers's Q1 2018 filing shows 303 new, 944 increased, 1,005 reduced and 237 closed positions. Its largest new stake was Procter & Gamble: 3,490,366 shares worth $277M. The largest sale was Amgen, an estimated $277M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Two Sigma Advisers's largest Q1 2018 buy was Procter & Gamble: 3,490,366 shares worth $277M.
- Two Sigma Advisers added most to PepsiCo in Q1 2018, an estimated $240M increase.
- Two Sigma Advisers's biggest Q1 2018 reduction was Amgen, cutting an estimated $277M.
- Two Sigma Advisers fully exited Constellation Brands in Q1 2018, selling an estimated $115M.
- Two Sigma Advisers's ten largest holdings make up 8.4% of its $36.9B portfolio in Q1 2018.
- Two Sigma Advisers opened 303 new positions and closed 237 in Q1 2018.
- Two Sigma Advisers's portfolio value fell 0.58% quarter-over-quarter to $36.9B.
Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.